MICHAEL WHITE to Pancreatic Neoplasms
This is a "connection" page, showing publications MICHAEL WHITE has written about Pancreatic Neoplasms.
Connection Strength
1.288
-
ASO Author Reflections: Potential Role of Circulating Biomarkers in Resected Pancreatic Adenocarcinoma. Ann Surg Oncol. 2021 Aug; 28(8):4623-4624.
Score: 0.453
-
Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2021 Aug; 28(8):4615-4622.
Score: 0.451
-
Impact of pancreatic cancer and subsequent resection on glycemic control in diabetic and nondiabetic patients. Am Surg. 2011 Aug; 77(8):1032-7.
Score: 0.234
-
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nat Commun. 2015 Apr 09; 6:6744.
Score: 0.076
-
MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies. Cell Rep. 2014 Dec 24; 9(6):2233-49.
Score: 0.074